Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166.

A new study finds half of all patients did not take enough blood pressure readings, with one third taking none at all.

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...

The NACP is the only federal program dedicated to monitoring, managing, and preventing asthma. It provides critical funding ...

Chamber scored a $60 million series A funding round to build out its tech-enabled delivery platform that supports cardiologists in value-based care models. | Chamber scored a $60 million series A ...

U.S. DHS in 2025 signed an agreement to give federal immigration enforcement officers broad access to the medical records of Medicaid patients.

Broeden Sabin, a 17-year-old Taunton high school student living in Fall River, was diagnosed with a high-risk form of leukemia. How you can help.

Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular ...

A new commitment will support a program that familiarizes internationally trained physicians with medical English and the ...

Many believe the federal program limits healthcare organizations and hospitals from providing discounted medications.

Under the leadership of our hospital president and chief operating officer, Kevin Whitney, Cooley Dickinson remains committed ...

The Trump administration has named 15 additional medicines for federal price talks, signaling a ...